Besides HER2 or HER2-related peptides, non-HER2-related antigens are also studied in vaccination for breast cancer, indicating opportunities of using cancer vaccines to treat HER2-negative breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.